Brewin Dolphin Wealth Management’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-83	Closed	-$9.58K	–	327
2020 Q4	$9.58K	Hold	83	–	–	﹤0.01%	248
2020 Q3	$8.08K	Hold	83	–	–	﹤0.01%	240
2020 Q2	$10.2K	Hold	83	–	–	﹤0.01%	252
2020 Q1	$7.27K	Hold	83	–	–	﹤0.01%	178
2019 Q4	$8.68K	Hold	83	–	–	﹤0.01%	179
2019 Q3	$9.55K	Hold	83	–	–	﹤0.01%	174
2019 Q2	$14.3K	Hold	83	–	–	0.01%	168
2019 Q1	$14K	Hold	83	–	–	0.01%	165
2018 Q4	$8.08K	Hold	83	–	–	﹤0.01%	167
2018 Q3	$14.3K	Hold	83	–	–	0.01%	167
2018 Q2	$11.6K	Hold	83	–	–	0.01%	170
2018 Q1	$9.35K	Hold	83	–	–	0.01%	161
2017 Q4	$11K	Hold	83	–	–	0.01%	147
2017 Q3	$8.42K	Buy	+83	New	+$8.89K	0.01%	143

Other funds holding GWPH

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brewin Dolphin Wealth Management's GWPH Position: Q1 2021 in Review

Brewin Dolphin Wealth Management sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q1 2021, closing a stake of 83 shares — an estimated $9.58K sold.

Brewin Dolphin Wealth Management first reported a position in GWPH in Q3 2017 and held it in 14 quarters. The position peaked at $14.3K in Q3 2018. 297 funds tracked by Wall St. Rank hold GWPH as of Q1 2021.

Brewin Dolphin Wealth Management reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q1 2021 after selling out during the quarter.
Brewin Dolphin Wealth Management sold 83 GW Pharmaceuticals Plc American Depositary Shares shares in Q1 2021, an estimated $9.58K.
Brewin Dolphin Wealth Management first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q3 2017 and held it in 14 quarters.
Brewin Dolphin Wealth Management's GW Pharmaceuticals Plc American Depositary Shares position peaked at $14.3K in Q3 2018.
297 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q1 2021.

Based on Brewin Dolphin Wealth Management's 13F filing for Q1 2021, filed 9 Nov 2023.